Status:
COMPLETED
SPC3649 Multiple Dose Study in Healthy Volunteers
Lead Sponsor:
Santaris Pharma A/S
Conditions:
Hepatitis C
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the safety and tolerability of SPC3649 given in multiple doses to healthy volunteers.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers: Males and postmenopausal females aged ≥ 18 to 60 years
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00979927
Start Date
September 1 2009
End Date
September 1 2010
Last Update
October 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PRA international
Zuidlaren, Netherlands, 9471